BioMedPartners and BB Pureos Bioventures have co-led a CHF 12.5m series-A for biotechnology company Alentis Therapeutics.
Vehicle was registered in Luxembourg in September 2018 and held a first close earlier in the year
Fund will follow the same strategy as its predecessor, Accel London V, which raised €500m
GP sells Dutch petrochemical business BRB to Malaysia-based peer Petronas Chemicals Group
GP acquires a 37.5% stake in the low-calorie drinks brand and typically writes cheques of up to £10m